levodopa has been researched along with Athetoid Movements in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (70.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 4 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lim, SY; Ng, RX; Tan, AH | 1 |
Borroni, B; Cotelli, MS; Filosto, M; Marchina, E; Padovani, A; Premi, E | 1 |
Abu-Arafeh, I; Combe, L | 1 |
Jurjevic, A; Kovacevic, M; Ljubicic, D; Mrsic-Pelcic, J; Perkovic, O; Rudez, J; Vitezic, D; Vitezic, M | 1 |
Blau, N; de Villemeur, TB; Doummar, D; Moller, LB; Roubergue, A; Roze, E; Vidailhet, M | 1 |
Diamond, SG; Markham, CH | 2 |
Coffey, CE; Ferren, EL; Olanow, CW; Ross, DR; Walker, JI | 1 |
Lees, AJ; Shaw, KM; Stern, GM | 1 |
Calne, DB; Eisler, T | 1 |
Filion, M; Langelier, P; Larochelle, L; Poirier, L | 1 |
Godwin-Austen, RB | 1 |
Basso, PF; Gasco, P; Montanini, R | 1 |
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
Reitter, B; Weisser, J | 1 |
Mawdsley, C | 1 |
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ | 1 |
Diamond, SG; Hoehn, MM; Markham, CH; McDowell, FH; Muenter, MD | 1 |
Markham, CH | 1 |
Diamond, SG; Markham, CH; Treciokas, LJ | 1 |
3 review(s) available for levodopa and Athetoid Movements
Article | Year |
---|---|
The pathogensis and medical treatment of extrapyramidal disease.
Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Administration Schedule; Dystonia; Female; gamma-Aminobutyric Acid; Glutamates; Haloperidol; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tic Disorders | 1979 |
Brain nervous mechanisms involved in the so-called extra pyramidal motor and psychomotor disturbances.
Topics: Animals; Athetosis; Basal Ganglia Diseases; Brain; Brain Stem; Cats; Corpus Striatum; Disease Models, Animal; Dopa Decarboxylase; Dopamine; Extrapyramidal Tracts; Globus Pallidus; Haplorhini; Homovanillic Acid; Humans; Levodopa; Monoamine Oxidase; Neural Pathways; Olivary Nucleus; Psychomotor Disorders; Red Nucleus; Tyrosine 3-Monooxygenase | 1975 |
Parkinson's disease and levodopa. A five-year follow-up and review.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Animals; Athetosis; Basal Ganglia; Chorea; Corpus Striatum; Dementia; Depression; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Sexual Behavior; Substantia Nigra; Vomiting | 1974 |
17 other study(ies) available for levodopa and Athetoid Movements
Article | Year |
---|---|
Osmotic Demyelination Syndrome With Evolving Movement Disorders.
Topics: Acute Disease; Adult; Akinetic Mutism; Athetosis; Benserazide; Chorea; Demyelinating Diseases; Dopamine Agents; Drug Combinations; Fluid Therapy; Gastroenteritis; Humans; Hyponatremia; Levodopa; Male; Myelinolysis, Central Pontine; Parkinsonian Disorders; Saline Solution; Time Factors | 2018 |
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype.
Topics: Antiparkinson Agents; Athetosis; Benzothiazoles; Chorea; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Magnetic Resonance Imaging; Middle Aged; Mutation; Neurologic Examination; Phenotype; Positron-Emission Tomography; Pramipexole; Protein Serine-Threonine Kinases; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tremor | 2013 |
Status dystonicus in children: Early recognition and treatment prevent serious complications.
Topics: Adolescent; Anti-Dyskinesia Agents; Athetosis; Baclofen; Cerebral Palsy; Child; Disease Progression; Dystonia; Female; Fluid Therapy; Humans; Infections; Levodopa; Male; Muscle Relaxants, Central; Retrospective Studies; Treatment Outcome | 2016 |
Sildenafil induced choreoathetosis in men with Parkinson's disease.
Topics: Antiparkinson Agents; Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2010 |
Long-term follow-up and adult outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency.
Topics: Adolescent; Adult; Antiparkinson Agents; Athetosis; Child; Child, Preschool; Chorea; Dose-Response Relationship, Drug; Dystonia; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Levodopa; Long-Term Care; Muscle Hypotonia; Neurologic Examination; Phenylketonurias; Phosphorus-Oxygen Lyases; Pterins; Treatment Outcome | 2006 |
One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease.
Topics: Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Hypotension; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1984 |
"On-off" syndrome treated with lithium carbonate: a case report.
Topics: Adult; Athetosis; Chorea; Humans; Levodopa; Lithium; Lithium Carbonate; Male; Parkinson Disease; Receptors, Dopamine | 1981 |
Evidence to support early levodopa therapy in Parkinson disease.
Topics: Athetosis; Chorea; Drug Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
"Off period" dystonia and "on period" choreoathetosis in levodopa-treated patients with Parkinson's disease.
Topics: Athetosis; Chorea; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease | 1977 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid | 1979 |
[Levodopa treatment of a case of torsion spasm with athetosis].
Topics: Athetosis; Child; Dystonia; Female; Humans; Levodopa; Spasm | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
[Familial paroxysmal choreoathetosis. Clinical course, L-dopa-effect (author's transl)].
Topics: Adolescent; Athetosis; Child; Child, Preschool; Chorea; Humans; Levodopa; Male | 1978 |
Diseases of the central nervous system. Involuntary movements.
Topics: Athetosis; Central Nervous System Diseases; Chorea; Face; Humans; Levodopa; Movement Disorders; Myoclonus; Parkinson Disease; Spasm; Tic Disorders; Torticollis; Tremor | 1975 |
(+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Cutaneous; Animals; Antiparkinson Agents; Athetosis; Chorea; Dopamine Agents; Levodopa; Oxazines; Saimiri | 1990 |
Effect of age at onset on progression and mortality in Parkinson's disease.
Topics: Aging; Athetosis; Chorea; Disability Evaluation; Humans; Levodopa; Middle Aged; Parkinson Disease | 1989 |
The "on-off" side effect of L-DOPA.
Topics: Age Factors; Amitriptyline; Aromatic Amino Acid Decarboxylase Inhibitors; Athetosis; Carbidopa; Catechol O-Methyltransferase Inhibitors; Chlordiazepoxide; Chorea; Desipramine; Diazepam; Dietary Proteins; Enzyme Inhibitors; Female; Humans; Imipramine; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Physical Exertion; Picolinic Acids; Prochlorperazine; Sex Factors; Stress, Psychological | 1974 |